MAP2K7 and gastric cancer: We observed the decreased phosphorylation of ERK and its downstream effector p90RSK in ALOX5‐depleted N87 cells (Figure 6), indicating that Alox5 inhibition suppresses the MEK/ERK pathway in gastric cancer cells.